Quinoline derivatives as alpha4beta7 integrin inhibitors
MYPI2025003621A0Undetermined Publication Date: 2020-04-30GILEAD SCIENCES INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- MYPI2025003621
- Authority / Receiving Office
- MY · MY
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2019-03-26
- Filing Date
- 2019-10-29
- Publication Date
- 2020-04-30
Abstract
QUINOLINE DERIVATIVES AS ALPHA4BETA7 INTEGRIN INHIBITORS The present disclosure provides a compound of Formula (I): (I); or a pharmaceutically acceptable salt thereof as described herein. The present disclosure also provides pharmaceutical compositions comprising a compound of Formula (I), processes for preparing compounds of Formula (I), and therapeutic methods for treating inflammatory disease.
Need to check novelty before this filing date? Find Prior Art
